Think Research Corporation
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Sachin Aggarwal
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 351 King St East Toronto ON Canada M5A 0L6
- IPO Date
- Aug 9, 2021
- Website
- thinkresearch.com
- Similar Companies
- Business
- Think Research Corporation is a Canadian health technology company specializing in delivering knowledge-based digital healthcare software solutions that support clinical decision-making, standardize care, and improve patient outcomes. Its core product offerings include cloud-based, EMR-agnostic digital tools such as clinical decision support systems; digital documentation and workflow solutions for primary care, acute care hospitals, surgical suites, community, and seniors care settings; eReferrals portal enabling physicians to send referrals directly from electronic medical records (EMRs); and virtual care platforms that facilitate online consultations via video, audio, chat, and secure messaging. The company also provides digital tools for improving operational efficiency in long-term and post-acute care, including admission and documentation management. Through its BioPharma Services subsidiary, Think Research delivers bioequivalence and Phase 1 clinical research services to pharmaceutical companies globally, managing pharmaceutical and clinical trial data. Think Research operates primarily in Canada with an expanding international footprint, licensing its digital solutions to over 14,200 healthcare facilities and serving more than 320,000 healthcare professionals worldwide. Founded in 2006 and headquartered in Toronto, Ontario, the company targets healthcare providers such as doctors, nurses, pharmacists, hospitals, clinics, long-term care centers, and pharmaceutical firms. Recent strategic developments include its April 2024 sale to Beedie Capital in a transaction valued at approximately C$85 million, marking Think Research's transition from a publicly listed to a privately held company. The company completed the acquisition of Pharmapod Limited's assets in October 2024, expanding its clinical electronic data capture capabilities and strengthening its SaaS offerings internationally. Additionally, Think Research completed the acquisition of BioPharma Services Inc., significantly enhancing its clinical research organization (CRO) segment and enabling greater integration of pharmaceutical data and clinical decision support. The company also secured a $5 million contract expansion with a global pharmaceutical client to augment its digital health and clinical trial data services. These changes reflect Think Research’s ongoing commitment to scaling its digital health platform and expanding its solution portfolio to drive improved healthcare outcomes globally.
Think Research Corporation Announces Completion of Plan of Arrangement
Think Research Provides Update on Going Private Transaction
Leading Independent Proxy Advisory Firm ISS Recommends Think Research Corporation Shareholders Approve The Arrangement With Beedie Capital
Think Research's Pharmapod Adopted in University and Colleges Across Canada to Teach Foundations of Medication Safety
Think Research Announces a $5.0 Million Contract Expansion with a Global Pharmaceutical Company
Think Research Enters into Definitive Agreement to be Acquired by Beedie Capital
Beedie Investments Ltd. Amends Convertible Loan Facility with Think Research Corporation
Think Research Announces Agreement for Subsequent Advance Under Existing Convertible Facility
Beedie Investments Ltd. Amends Convertible Loan Facility with Think Research Corporation
Think Research Announces Agreement for Subsequent Advance Under Existing Convertible Facility
Think Research's Learning Management System to Support Healthcare Professional Education and Training
Think Research Announces Grant of Equity Compensation
Think Research Corporation Announces Third Quarter 2023 Results
Think Research Announces Date of Third Quarter and Year-to-date 2023 Results and Conference Call Details
Think Research Announces Agreement for Subsequent Advance Under Existing Convertible Facility
Beedie Investments Ltd. Amends Convertible Loan Facility with Think Research Corporation
Think Research Supporting the Province of Nova Scotia's YourHealthNS Initiative to Provide Better Access to Care, Information Across the Province
Beedie Investments Limited Announces Agreement for Subsequent Advance Under Existing Convertible Facility with Think Research Corporation
Think Research posts 82% jump in 3Q revenue on optimized operations and streamlined costs
Think Research says Beedie Investments approves second advance from current credit agreement; gives positive outlook